Walgreens Boots Alliance (WBA) Stock: Charts & Financials

Walgreens Boots Alliance, Inc. (WBA)WBAWalgreens Boots Alliance, Inc.

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.

Deerfield, IL

193,000 employees

www.walgreensbootsalliance.com

Healthcare / Medical - Pharmaceuticals

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO: Timothy C. Wentworth

View full financials

Quarterly Report	TTM	Quarter ended May 2025	Quarter ended Feb 2025	Quarter ended Nov 2024	Quarter ended Aug 2024	Quarter ended May 2024	Quarter ended Feb 2024	Quarter ended Nov 2023	Quarter ended Aug 2023
Revenue	154.58B	38.99B	38.59B	39.46B	37.55B	36.35B	37.05B	36.71B	35.42B
Cost of Goods Sold	128.11B	32.48B	31.65B	32.68B	31.29B	29.89B	30.01B	29.94B	28.95B
Gross Profit	26.47B	6.51B	6.93B	6.78B	6.25B	6.46B	7.04B	6.77B	6.47B
Gross Profit Margin	17.1%	16.7%	18.0%	17.2%	16.7%	17.8%	19.0%	18.4%	18.3%
Total Operating Expenses	33.21B	6.45B	12.50B	7.02B	7.23B	6.35B	20.21B	6.81B	6.93B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	29.35B	6.49B	8.89B	7.01B	6.95B	6.39B	7.92B	6.85B	6.99B
Operating Income (EBIT)	-3.12B	53.00M	-1.96B	-236.00M	-977.00M	111.00M	-13.17B	-39.00M	-451.00M
Operating Margin	-2.0%	0.1%	-5.1%	-0.6%	-2.6%	0.3%	-35.5%	-0.1%	-1.3%
Income Before Tax (EBT)	-5.85B	-70.00M	-4.25B	-539.00M	-998.00M	250.00M	-13.10B	-352.00M	-58.00M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	508.00M	126.00M	129.00M	122.00M	131.00M	113.00M	138.00M	99.00M	155.00M
Other Income/Expense	-2.74B	-123.00M	-2.29B	-303.00M	-21.00M	139.00M	67.00M	-313.00M	393.00M
Net Income	-6.30B	-175.00M	-2.85B	-265.00M	-3.00B	344.00M	-5.91B	-67.00M	-180.00M
Income Tax Expense	2.06B	126.00M	-212.00M	66.00M	2.08B	20.00M	-782.00M	-74.00M	151.00M
Net Profit Margin	-4.1%	-0.4%	-7.4%	-0.7%	-8.0%	0.9%	-15.9%	-0.2%	-0.5%
EBITDA	-685.00M	626.00M	-1.34B	389.00M	-355.00M	718.00M	-12.56B	577.00M	154.00M
EBITDA Margin	-0.4%	1.6%	-3.5%	1.0%	-0.9%	2.0%	-33.9%	1.6%	0.4%
Depreciation & Amortization	2.43B	573.00M	611.00M	625.00M	622.00M	607.00M	614.00M	616.00M	605.00M
EPS Basic	-7.29	-0.20	-3.30	-0.31	-3.48	0.40	-6.85	-0.08	-0.21
EPS Diluted	-7.29	-0.20	-3.30	-0.31	-3.48	0.40	-6.85	-0.08	-0.21
Shares Outstanding	864.90M	864.90M	864.10M	863.80M	863.70M	863.10M	862.50M	863.00M	864.30M
Diluted Shares Outstanding	864.90M	864.90M	864.10M	863.80M	863.70M	864.30M	862.50M	863.00M	864.30M

Quarterly Report

TTM

Quarter ended May 2025

Quarter ended Feb 2025

Quarter ended Nov 2024

Quarter ended Aug 2024

Quarter ended May 2024

Quarter ended Feb 2024

Quarter ended Nov 2023

Quarter ended Aug 2023

Revenue

154.58B

38.99B

38.59B

39.46B

37.55B

36.35B

37.05B

36.71B

35.42B

Cost of Goods Sold

128.11B

32.48B

31.65B

32.68B

31.29B

29.89B

30.01B

29.94B

28.95B

Gross Profit

26.47B

6.51B

6.93B

6.78B

6.25B

6.46B

7.04B

6.77B

6.47B

Gross Profit Margin

17.1%

16.7%

18.0%

17.2%

16.7%

17.8%

19.0%

18.4%

18.3%

Total Operating Expenses

33.21B

6.45B

12.50B

7.02B

7.23B

6.35B

20.21B

6.81B

6.93B

Research & Development

N/A

Selling, General & Administrative

29.35B

6.49B

8.89B

7.01B

6.95B

6.39B

7.92B

6.85B

6.99B

Operating Income (EBIT)

-3.12B

53.00M

-1.96B

-236.00M

-977.00M

111.00M

-13.17B

-39.00M

-451.00M

Operating Margin

-2.0%

0.1%

-5.1%

-0.6%

-2.6%

0.3%

-35.5%

-0.1%

-1.3%

Income Before Tax (EBT)

-5.85B

-70.00M

-4.25B

-539.00M

-998.00M

250.00M

-13.10B

-352.00M

-58.00M

Interest Income

N/A

Interest Expense

508.00M

126.00M

129.00M

122.00M

131.00M

113.00M

138.00M

99.00M

155.00M

Other Income/Expense

-2.74B

-123.00M

-2.29B

-303.00M

-21.00M

139.00M

67.00M

-313.00M

393.00M

Net Income

-6.30B

-175.00M

-2.85B

-265.00M

-3.00B

344.00M

-5.91B

-67.00M

-180.00M

Income Tax Expense

2.06B

126.00M

-212.00M

66.00M

2.08B

20.00M

-782.00M

-74.00M

151.00M

Net Profit Margin

-4.1%

-0.4%

-7.4%

-0.7%

-8.0%

0.9%

-15.9%

-0.2%

-0.5%

EBITDA

-685.00M

626.00M

-1.34B

389.00M

-355.00M

718.00M

-12.56B

577.00M

154.00M

EBITDA Margin

-0.4%

1.6%

-3.5%

1.0%

-0.9%

2.0%

-33.9%

1.6%

0.4%

Depreciation & Amortization

2.43B

573.00M

611.00M

625.00M

622.00M

607.00M

614.00M

616.00M

605.00M

EPS Basic

-7.29

-0.20

-3.30

-0.31

-3.48

0.40

-6.85

-0.08

-0.21

EPS Diluted

-7.29

-0.20

-3.30

-0.31

-3.48

0.40

-6.85

-0.08

-0.21

Shares Outstanding

864.90M

864.10M

863.80M

863.70M

863.10M

862.50M

863.00M

864.30M

Diluted Shares Outstanding

864.90M

864.10M

863.80M

863.70M

864.30M

862.50M

863.00M

864.30M

Annual Report	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020	08/31/2019	08/31/2018	08/31/2017
Revenue	147.66B	139.08B	132.70B	132.51B	121.98B	120.07B	131.54B	118.21B
Cost of Goods Sold	121.13B	112.01B	104.44B	104.44B	95.91B	91.92B	100.75B	89.05B
Gross Profit	26.52B	27.07B	28.27B	28.07B	26.08B	28.16B	30.79B	29.16B
Gross Profit Margin	18.0%	19.5%	21.3%	21.2%	21.4%	23.5%	23.4%	24.7%
Total Operating Expenses	40.60B	33.95B	26.88B	25.73B	25.09B	23.39B	24.50B	23.68B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	28.11B	34.20B	27.30B	24.59B	25.44B	23.56B	24.69B	23.81B
Operating Income (EBIT)	-14.08B	-6.88B	1.39B	2.34B	982.00M	4.77B	6.29B	5.48B
Operating Margin	-9.5%	-4.9%	1.0%	1.8%	0.8%	4.0%	4.8%	4.6%
Income Before Tax (EBT)	-14.20B	-5.39B	4.04B	2.62B	477.00M	4.37B	6.03B	4.86B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	482.00M	580.00M	400.00M	905.00M	613.00M	650.00M	616.00M	693.00M
Other Income/Expense	-126.00M	1.46B	2.65B	280.00M	-505.00M	-399.00M	-260.00M	-623.00M
Net Income	-8.64B	-3.08B	4.34B	2.54B	456.00M	3.98B	5.02B	4.08B
Income Tax Expense	1.25B	-1.86B	-30.00M	667.00M	339.00M	577.00M	998.00M	760.00M
Net Profit Margin	-5.8%	-2.2%	3.3%	1.9%	0.4%	3.3%	3.8%	3.4%
EBITDA	-11.62B	-4.63B	3.38B	4.32B	2.91B	6.80B	8.06B	7.14B
EBITDA Margin	-7.9%	-3.3%	2.5%	3.3%	2.4%	5.7%	6.1%	6.0%
Depreciation & Amortization	2.46B	2.26B	1.99B	1.97B	1.93B	2.04B	1.77B	1.65B
EPS Basic	-10.01	-3.57	5.02	2.31	0.52	4.14	5.07	3.80
EPS Diluted	-10.01	-3.57	5.01	2.30	0.52	4.13	5.05	3.78
Shares Outstanding	863.10M	863.20M	864.40M	864.80M	879.40M	921.50M	991.00M	1.07B
Diluted Shares Outstanding	863.10M	863.20M	865.90M	866.40M	880.30M	923.50M	995.00M	1.08B

Annual Report

08/31/2024

08/31/2023

08/31/2022

08/31/2021

08/31/2020

08/31/2019

08/31/2018

08/31/2017

Revenue

147.66B

139.08B

132.70B

132.51B

121.98B

120.07B

131.54B

118.21B

Cost of Goods Sold

121.13B

112.01B

104.44B

95.91B

91.92B

100.75B

89.05B

Gross Profit

26.52B

27.07B

28.27B

28.07B

26.08B

28.16B

30.79B

29.16B

Gross Profit Margin

18.0%

19.5%

21.3%

21.2%

21.4%

23.5%

23.4%

24.7%

Total Operating Expenses

40.60B

33.95B

26.88B

25.73B

25.09B

23.39B

24.50B

23.68B

Research & Development

N/A

Selling, General & Administrative

28.11B

34.20B

27.30B

24.59B

25.44B

23.56B

24.69B

23.81B

Operating Income (EBIT)

-14.08B

-6.88B

1.39B

2.34B

982.00M

4.77B

6.29B

5.48B

Operating Margin

-9.5%

-4.9%

1.0%

1.8%

0.8%

4.0%

4.8%

4.6%

Income Before Tax (EBT)

-14.20B

-5.39B

4.04B

2.62B

477.00M

4.37B

6.03B

4.86B

Interest Income

N/A

Interest Expense

482.00M

580.00M

400.00M

905.00M

613.00M

650.00M

616.00M

693.00M

Other Income/Expense

-126.00M

1.46B

2.65B

280.00M

-505.00M

-399.00M

-260.00M

-623.00M

Net Income

-8.64B

-3.08B

4.34B

2.54B

456.00M

3.98B

5.02B

4.08B

Income Tax Expense

1.25B

-1.86B

-30.00M

667.00M

339.00M

577.00M

998.00M

760.00M

Net Profit Margin

-5.8%

-2.2%

3.3%

1.9%

0.4%

3.3%

3.8%

3.4%

EBITDA

-11.62B

-4.63B

3.38B

4.32B

2.91B

6.80B

8.06B

7.14B

EBITDA Margin

-7.9%

-3.3%

2.5%

3.3%

2.4%

5.7%

6.1%

6.0%

Depreciation & Amortization

2.46B

2.26B

1.99B

1.97B

1.93B

2.04B

1.77B

1.65B

EPS Basic

-10.01

-3.57

5.02

2.31

0.52

4.14

5.07

3.80

EPS Diluted

-10.01

-3.57

5.01

2.30

0.52

4.13

5.05

3.78

Shares Outstanding

863.10M

863.20M

864.40M

864.80M

879.40M

921.50M

991.00M

1.07B

Diluted Shares Outstanding

863.10M

863.20M

865.90M

866.40M

880.30M

923.50M

995.00M

1.08B

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)